
### [NCIT:C5171](http://purl.obolibrary.org/obo/NCIT_C5171)
**Label:** Metastatic Breast Carcinoid Tumor

**Subclasses:** 

**Class expressions from DL-Learner:**

- Thing 53.20%
- [NCIT:C36933](http://purl.obolibrary.org/obo/NCIT_C36933) (Neoplastic Neuroendocrine Polygonal Cell) and (not ([NCIT:C36855](http://purl.obolibrary.org/obo/NCIT_C36855) (Malignant Neuroendocrine Polygonal Cell))) 53.12%
- [NCIT:C36933](http://purl.obolibrary.org/obo/NCIT_C36933) (Neoplastic Neuroendocrine Polygonal Cell) 38.48%
- [NCIT:C36933](http://purl.obolibrary.org/obo/NCIT_C36933) (Neoplastic Neuroendocrine Polygonal Cell) and (not ([NCIT:C40165](http://purl.obolibrary.org/obo/NCIT_C40165) (Uterine Corpus Apoplectic Leiomyoma))) 38.48%
- [NCIT:C36933](http://purl.obolibrary.org/obo/NCIT_C36933) (Neoplastic Neuroendocrine Polygonal Cell) and (not ([NCIT:C40164](http://purl.obolibrary.org/obo/NCIT_C40164) (Uterine Corpus Epithelioid Leiomyoma))) 38.48%
- [NCIT:C36933](http://purl.obolibrary.org/obo/NCIT_C36933) (Neoplastic Neuroendocrine Polygonal Cell) and (not ([NCIT:C40163](http://purl.obolibrary.org/obo/NCIT_C40163) (Uterine Corpus Cellular Leiomyoma))) 38.48%
- [NCIT:C36933](http://purl.obolibrary.org/obo/NCIT_C36933) (Neoplastic Neuroendocrine Polygonal Cell) and (not ([NCIT:C40162](http://purl.obolibrary.org/obo/NCIT_C40162) (Uterine Corpus Leiomyoma, Mitotically Active Variant))) 38.48%
- [NCIT:C36933](http://purl.obolibrary.org/obo/NCIT_C36933) (Neoplastic Neuroendocrine Polygonal Cell) and (not ([NCIT:C40161](http://purl.obolibrary.org/obo/NCIT_C40161) (JAZF1-SUZ12 Fusion Protein Expression))) 38.48%
- [NCIT:C36933](http://purl.obolibrary.org/obo/NCIT_C36933) (Neoplastic Neuroendocrine Polygonal Cell) and (not ([NCIT:C40160](http://purl.obolibrary.org/obo/NCIT_C40160) (t(7;17)(p15;q21)))) 38.48%
- [NCIT:C36933](http://purl.obolibrary.org/obo/NCIT_C36933) (Neoplastic Neuroendocrine Polygonal Cell) and (not ([NCIT:C40156](http://purl.obolibrary.org/obo/NCIT_C40156) (Endometrial Undifferentiated Carcinoma))) 38.48%
- [NCIT:C36933](http://purl.obolibrary.org/obo/NCIT_C36933) (Neoplastic Neuroendocrine Polygonal Cell) and (not ([NCIT:C40155](http://purl.obolibrary.org/obo/NCIT_C40155) (Endometrial Small Cell Carcinoma))) 38.48%
- [NCIT:C36933](http://purl.obolibrary.org/obo/NCIT_C36933) (Neoplastic Neuroendocrine Polygonal Cell) and (not ([NCIT:C40154](http://purl.obolibrary.org/obo/NCIT_C40154) (Endometrial Transitional Cell Carcinoma))) 38.48%
- [NCIT:C36933](http://purl.obolibrary.org/obo/NCIT_C36933) (Neoplastic Neuroendocrine Polygonal Cell) and (not ([NCIT:C40153](http://purl.obolibrary.org/obo/NCIT_C40153) (Endometrial Mixed Adenocarcinoma))) 38.48%
- [NCIT:C36933](http://purl.obolibrary.org/obo/NCIT_C36933) (Neoplastic Neuroendocrine Polygonal Cell) and (not ([NCIT:C40152](http://purl.obolibrary.org/obo/NCIT_C40152) (Serous Endometrial Intraepithelial Carcinoma))) 38.48%
- [NCIT:C36933](http://purl.obolibrary.org/obo/NCIT_C36933) (Neoplastic Neuroendocrine Polygonal Cell) and (not ([NCIT:C40151](http://purl.obolibrary.org/obo/NCIT_C40151) (Grade 3 Endometrial Mucinous Adenocarcinoma))) 38.48%


